Mercaptopropionic Acid

Mercaptopropionic Acid

SCHEMBL574355

O=C(O)CCS.O=C(O)CCS.O=C(O)CCS.O=C(O)CCS.O=C(O)CS.O=C(O)CS.O=C(O)CS.O=C(O)CS.OCC(CO)(CO)CO.OCC(CO)(CO)CO

nearest known ligand 0.46

Full drug profile on Sugi Atlas →

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
ACE P12821 1/20 0.46
FOLH1 Q04609 7/20 0.42
ENPEP Q07075 6/20 0.40
ANPEP P15144 3/20 0.40
LMNA P02545 1/20 0.36
ALKBH5 Q6P6C2 1/20 0.36
SUCNR1 Q9BXA5 1/20 0.36
EGLN1 Q9GZT9 1/20 0.36
CAMK2A Q9UQM7 1/20 0.35
GSTK1 Q9Y2Q3 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Mercaptopropionic Acid SCHEMBL330800 0.95 ACE (0.50) ACEFOLH1ENPEPANPEPLMNA
Mercaptopropionic Acid SCHEMBL331658 0.95 ACE (0.50) ACEFOLH1ENPEPANPEPLMNA
Mercaptopropionic Acid SCHEMBL1900470 0.95 ACE (0.50) ACEFOLH1ENPEPANPEPLMNA
Mercaptopropionic Acid SCHEMBL863468 0.95 ACE (0.50) ACEFOLH1ENPEPANPEPLMNA
Mercaptopropionic Acid SCHEMBL56209 0.95 ACE (0.50) ACEFOLH1ENPEPANPEPLMNA
Mercaptopropionic Acid SCHEMBL331852 0.95 ACE (0.50) ACEFOLH1ENPEPANPEPLMNA
Mercaptopropionic Acid SCHEMBL99518 0.95 ACE (0.50) ACEFOLH1ENPEPANPEPLMNA
Mercaptopropionic Acid SCHEMBL330873 0.95 ACE (0.50) ACEFOLH1ENPEPANPEPLMNA
Mercaptopropionic Acid SCHEMBL996885 0.95 ACE (0.50) ACEFOLH1ENPEPANPEPLMNA
Mercaptopropionic Acid SCHEMBL14829321 0.95 ACE (0.50) ACEFOLH1ENPEPANPEPLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 65 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2938652-B1 POLYMERIZABLE COMPOSITION INCLUDING A BENZOXAZINE AND AN ACID-FORMING PEROXIDE CATALYST, ARTICLE, AND METHOD 3M INNOVATIVE PROPERTIES CO (US) 2021-03-31 EP disclosed
US-10882955-B2 Ammonium salt catalyzed benzoxazine polymerization 3M INNOVATIVE PROPERTIES COMPANY (US) 2021-01-05 US disclosed
EP-3512895-B1 BENZOXAZINE COMPOSITION 3M INNOVATIVE PROPERTIES CO (US) 2020-11-04 EP disclosed
EP-3233811-B1 CURABLE BENZOXAZINE COMPOSITIONS WITH IMPROVED THERMAL STABILITY 3M INNOVATIVE PROPERTIES CO (US) 2020-09-09 EP disclosed
US-10731003-B2 Benzoxazine composition 3M INNOVATIVE PROPERTIES COMPANY (US) 2020-08-04 US disclosed
US-10556991-B2 Benzoxazine and phthalonitrile resin blends 3M INNOVATIVE PROPERTIES COMPANY (US) 2020-02-11 US disclosed
EP-3512895-A1 BENZOXAZINE COMPOSITION 3M Innovative Properties Company (US) 2019-07-24 EP disclosed
US-20190169370-A1 BENZOXAZINE COMPOSITION 3M INNOVATIVE PROPERTIES COMPANY 2019-06-06 US disclosed
EP-2438107-B1 BENZOXAZINE-THIOL ADDUCTS 3M INNOVATIVE PROPERTIES CO (US) 2019-01-02 EP disclosed
US-20180312637-A1 Benzoxazine and Phthalonitrile Resin Blends 3M INNOVATIVE PROPERTIES COMPANY 2018-11-01 US disclosed
US-20100307680-A1 BENZOXAZINE-THIOL ADDUCTS 3M INNOVATIVE PROPERTIES COMPANY 2010-12-09 US disclosed
US-20100312004-A1 BENZOXAZINE-THIOL ADDUCTS 3M INNOVATIVE PROPERTIES COMPANY 2010-12-09 US disclosed
WO-2010141397-A1 ADHESIVE COMPOSITION BASED ON BENZOXAZINE-THIOL ADDUCTS 3M INNOVATIVE PROPERTIES COMPANY (US) 2010-12-09 WO disclosed
EP-2255401-A1 NONWOVEN FABRIC HAVING CROSS-LINKING MATERIAL Carl Freudenberg KG (DE) 2010-12-01 EP disclosed
WO-2009103537-A1 NONWOVEN FABRIC HAVING CROSS-LINKING MATERIAL CARL FREUDENBERG KG (DE) 2009-08-27 WO disclosed
US-7521015-B2 Curable thiol-ene compositions for optical articles 3M INNOVATIVE PROPERTIES COMPANY (US) 2009-04-21 US disclosed
EP-1907428-B1 CURABLE THIOL-ENE COMPOSITIONS FOR OPTICAL ARTICLES 3M INNOVATIVE PROPERTIES CO (US) 2008-12-03 EP disclosed
EP-1907428-A1 CURABLE THIOL-ENE COMPOSITIONS FOR OPTICAL ARTICLES 3M Innovative Properties Company (US) 2008-04-09 EP disclosed
WO-2007015815-A1 CURABLE THIOL-ENE COMPOSITIONS FOR OPTICAL ARTICLES 3M INNOVATIVE PROPERTIES COMPANY (US) 2007-02-08 WO disclosed
US-20070021521-A1 Curable thiol-ene compositions for optical articles 3M INNOVATIVE PROPERTIES COMPANY 2007-01-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100312004-A1 BENZOXAZINE-THIOL ADDUCTS AOX1, GJA1, PRDX4 ACE 2645/4885FOLH1 2621/4885ENPEP 1724/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.